| Human papillomavirus and oral squamous cell carcinoma: A review of HPV-positive oral squamous cell carcinoma and possible strategies for future S Jiang, Y Dong Current problems in cancer 41 (5), 323-327, 2017 | 130 | 2017 |
| Effectiveness of remdesivir for the treatment of hospitalized COVID‐19 persons: a network meta‐analysis Y Jiang, D Chen, D Cai, Y Yi, S Jiang Journal of medical virology 93 (2), 1171-1174, 2021 | 56 | 2021 |
| Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life D Cai, S Shi, S Jiang, L Si, J Wu, Y Jiang The European Journal of Health Economics, 1-9, 2022 | 41 | 2022 |
| Tertiary hospitals or community clinics? An enquiry into the factors affecting patients' choice for healthcare facilities in urban China S Jiang, Y Gu, F Yang, T Wu, H Wang, H Cutler, L Zhang China Economic Review 63, 101538, 2020 | 25 | 2020 |
| The cost-effectiveness of conducting three versus two reverse transcription-polymerase chain reaction tests for diagnosing and discharging people with COVID-19: evidence from … Y Jiang, D Cai, D Chen, S Jiang BMJ global health 5 (7), e002690, 2020 | 23 | 2020 |
| Do rural residents in China understand EQ-5D-5L as intended? Evidence from a qualitative study F Yang, S Jiang, X He, H Li, H Wu, T Zhang, J Wu PharmacoEconomics-open 5, 101-109, 2021 | 21 | 2021 |
| Impact of public hospital pricing reform on medical expenditure structure in Jiangsu, China: a synthetic control analysis X Zang, M Zhang, S Wei, W Tang, S Jiang BMC health services research 19, 1-9, 2019 | 19 | 2019 |
| Difficulty and help with activities of daily living among older adults living alone during the COVID-19 pandemic: a multi-country population-based study S Chen, LA Jones, S Jiang, H Jin, D Dong, X Chen, D Wang, Y Zhang, ... BMC geriatrics 22 (1), 181, 2022 | 17 | 2022 |
| Economic evaluation of remdesivir for the treatment of severe COVID‐19 patients in China under different scenarios Y Jiang, D Cai, D Chen, S Jiang, L Si, J Wu British Journal of Clinical Pharmacology 87 (11), 4386-4396, 2021 | 16 | 2021 |
| Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China S Jiang, Y Wang, L Si, X Zang, YY Gu, Y Jiang, GG Liu, J Wu BMJ Global Health 7 (8), e009777, 2022 | 15 | 2022 |
| Warm-needling acupuncture and medicinal cake-separated moxibustion for hyperlipidemia: study protocol for a randomized controlled trial M Liu, Q Zhang, S Jiang, M Liu, G Zhang, Z Yue, Q Chen, J Zhou, Y Zou, ... Trials 18, 1-17, 2017 | 13 | 2017 |
| Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing S Jiang, Z Chen, T Wu, H Wang Journal of Global Health 10 (1), 2020 | 12 | 2020 |
| Health-care practitioners’ preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment S Jiang, AH Anis, I Cromwell, T Mohammadi, KA Schrader, J Lucas, ... Genetics in Medicine 22 (12), 2011-2019, 2020 | 11 | 2020 |
| Pharmacoeconomics of obesity in China: a scoping review Z Chen, S Jiang, Y Wang, MM Khan, D Zhang, J Rajbhandari-Thapa, L Li Expert Review of Pharmacoeconomics & Outcomes Research 21 (2), 173-181, 2021 | 10 | 2021 |
| Addressing methodological and ethical issues in practicing health economic evaluation in China S Jiang, Z Chen, J Wu, X Zang, Y Jiang Journal of global health 10 (2), 2020 | 10 | 2020 |
| Patient preferences in targeted pharmacotherapy for cancers: A systematic review of discrete choice experiments S Jiang, R Ren, Y Gu, V Jeet, P Liu, S Li PharmacoEconomics, 2022 | 9 | 2022 |
| Incorporating future unrelated medical costs in cost-effectiveness analysis in China S Jiang, Y Wang, J Zhou, Y Jiang, GG Liu, J Wu BMJ Global Health 6 (10), e006655, 2021 | 9 | 2021 |
| A scoping review of global guidelines for the disclosure of secondary genomic findings to inform the establishment of guidelines in China S Jiang China CDC Weekly 4 (32), 697, 2022 | 8 | 2022 |
| Breast cancer screening should embrace precision medicine: evidence by reviewing economic evaluations in China J Jiang, S Jiang, A Ahumada-Canale, Z Chen, L Si, Y Jiang, L Yang, Y Gu Advances in Therapy 40 (4), 1393-1417, 2023 | 7 | 2023 |
| Identifying options of best value: use of economic evaluation in public health Z Chen, L Zhou, S Jiang, A Haddix China CDC Weekly 2 (5), 75, 2020 | 5 | 2020 |
Yuanyuan GuMacquarie UniversityVerified email at mq.edu.au
